Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

0 of 10 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

6(37.5%)

Phase 1

5(31.3%)

Phase 4

3(18.8%)

Phase 2

2(12.5%)

16Total

N/A(6)

Phase 1(5)

Phase 4(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT06308952Phase 4Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

Role: collaborator

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Role: collaborator

NCT07353736Not Yet Recruiting

Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis

Role: collaborator

NCT06966830Not Yet Recruiting

Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus

Role: collaborator

NCT05289908Phase 1Completed

Intrathecal Pemetrexed for Leptomeningeal Metastasis

Role: collaborator

NCT06763848Not ApplicableRecruiting

Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder

Role: collaborator

NCT04198181Active Not Recruiting

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

Role: collaborator

NCT04198207Completed

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Role: collaborator

NCT06446778Recruiting

Pipeline Embolization for Intracranial Aneurysms

Role: collaborator

NCT03133598Completed

Treatment of Unruptured Intracranial Aneurysms in China

Role: collaborator

NCT03387995Completed

Safety and Efficacy of Stent Deployment for Intracranial Aneurysms (SESIA)

Role: collaborator

NCT03207100Not ApplicableCompleted

Analgesia-first Minimal Sedation for Spontaneous Intracerebral Hemorrhage Early Antihypertensive Treatment

Role: collaborator

NCT06032819Unknown

Differentiating Between Brain Hemorrhage and Contrast

Role: collaborator

NCT05305885Not ApplicableUnknown

Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis

Role: collaborator

NCT02808364Phase 1Completed

Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)

Role: lead

NCT02808416Phase 1Completed

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

Role: lead

NCT02709616Phase 1Completed

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Role: lead

NCT04514393Phase 2Unknown

Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma

Role: collaborator

NCT03033693Not ApplicableCompleted

Study of the Depth of Anesthesia on Postoperative Clinical Outcome in Patients With Supratentorial Tumor

Role: collaborator

NCT05021770Phase 1Unknown

Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

Role: collaborator